Depakote ER Side Effects: What to Expect and When to Call Your Doctor

Depakote ER (divalproex sodium extended-release) is an effective medication for epilepsy, bipolar disorder, and migraine prevention, but like all medications, it comes with side effects. Some are common and manageable. Others are rare but serious — including life-threatening conditions with FDA black box warnings.

This guide walks through what to expect, what to watch for, and when to pick up the phone and call your provider.

FDA Black Box Warnings — The Most Serious Risks

Depakote ER carries three FDA black box warnings — the most serious level of safety warning the FDA issues. Every patient starting Depakote ER should be aware of these:

Hepatotoxicity (liver damage): Serious and potentially fatal liver damage has been reported, most commonly during the first 6 months of treatment. Risk is highest in children under 2 years and patients with mitochondrial disorders. Early symptoms include malaise, weakness, unusual tiredness, facial swelling, loss of appetite, and vomiting. Tell your doctor right away if you notice any of these.

Pancreatitis: Life-threatening inflammation of the pancreas has been reported in patients taking valproate, sometimes occurring years after starting the medication. Symptoms include severe abdominal pain, nausea, and vomiting. Depakote ER should be stopped immediately if pancreatitis is diagnosed.

Fetal risk: If taken during pregnancy, valproate can cause serious birth defects including neural tube defects (spina bifida), craniofacial abnormalities, heart defects, and reduced IQ in children. The risk is approximately four times higher than with other anticonvulsants. Women of childbearing age should discuss this risk thoroughly with their doctor and use effective contraception.

Common Side Effects of Depakote ER

These side effects are relatively common and often improve with time or dose adjustments:

Gastrointestinal upset: Nausea, vomiting, diarrhea, and stomach pain are among the most reported side effects. Taking Depakote ER with food can significantly reduce GI symptoms. Starting at a low dose and titrating slowly also helps.

Tremor: A fine tremor of the hands is common, particularly at higher doses. This may improve with dose reduction or the addition of a small dose of propranolol (ask your doctor first).

Weight gain: Weight gain is a frequently reported complaint. Monitoring diet and staying active can help manage this side effect.

Hair loss (alopecia): Some patients experience hair thinning or loss, especially at higher doses. This is usually reversible with dose reduction. Zinc and selenium supplementation has been reported to help in some cases — ask your doctor.

Drowsiness/somnolence: Especially common when first starting the medication or after dose increases. Avoid driving or operating heavy machinery until you know how the medication affects you.

Dizziness: Often most pronounced when first starting or after dose adjustments. Rise slowly from sitting or lying positions.

Headache: Reported in clinical trials, though paradoxically Depakote ER is also prescribed to prevent migraines.

Blurred vision: Visual disturbances have been reported and should be mentioned to your doctor if they occur.

Serious Side Effects to Watch For

Beyond the black box warnings, these serious side effects require prompt medical attention:

Suicidal thoughts or behavior: Like all anticonvulsants, Depakote ER carries an FDA warning about increased risk of suicidal ideation. Tell your doctor immediately if you notice new or worsening depression, anxiety, or unusual mood changes.

Hyperammonemia: Elevated blood ammonia levels can cause confusion, lethargy, and in severe cases, coma. Risk increases when valproate is taken with topiramate or fosphenytoin. Symptoms include confusion, unusual tiredness, or vomiting without other explanation.

Low platelet count (thrombocytopenia): Valproate can reduce platelet count, increasing bruising and bleeding risk. Signs include unusual bruising, prolonged bleeding from cuts, or blood in stool. Your CBC should be monitored regularly.

Hypothermia: Abnormally low body temperature has been reported, particularly when valproate is taken with other medications. This is rare but worth knowing about.

DRESS syndrome: A rare but serious drug hypersensitivity reaction involving rash, fever, swollen lymph nodes, and organ involvement. Seek emergency care if you develop a widespread rash with fever.

When to Call Your Doctor Right Away

Contact your prescriber immediately or go to the ER for:

Severe abdominal pain (may signal pancreatitis)

Yellowing of skin or eyes, dark urine, severe fatigue (signs of liver damage)

Widespread rash, especially with fever or swollen glands

Sudden confusion, extreme drowsiness, or difficulty being awakened

New or worsening suicidal thoughts or self-harm ideation

Unusual bruising or bleeding

If you become pregnant while taking Depakote ER

Monitoring Required While on Depakote ER

Regular monitoring is an essential part of taking Depakote ER safely. Your doctor should order:

Serum valproate levels (to ensure therapeutic range of 50–100 mcg/mL for epilepsy)

Liver function tests (LFTs) before starting and frequently during the first 6 months, then periodically

Complete blood count (CBC) with platelets to monitor for thrombocytopenia

The Bottom Line

Most patients on Depakote ER experience manageable side effects that improve over time. The serious risks — liver damage, pancreatitis, and fetal harm — require vigilance and regular monitoring. Never adjust your dose or stop taking Depakote ER without talking to your doctor first. For information on medications that interact with Depakote ER, see our guide on Depakote ER drug interactions. And if you ever have trouble filling your prescription, medfinder can help you find it in stock.